DWP16001

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Efficacy and SafetyType 2 Diabetes MellitusDiabetic NephropathyHepatic ImpairmentDrug Interactions

228 competitors in Efficacy and Safety

#DrugCompanyPhaseTrials

1

DWP16001

Daewoong Pharmaceutical Co. LTD.

Phase 3

12

Romiplostim N01

Qilu Pharmaceutical Co., Ltd.

Phase 3

13

S1,

CChinese Academy of Medical Sciences

Phase 3

14

Becotatug Vedotin

FFudan University

Phase 3

15

Imlifidase

HHansa Biopharma AB

Phase 3

26

TLL-018

HHangzhou Highlightll Pharmaceutical Co., Ltd

Phase 3

17

IN-B00009

HHK inno.N Corporation

Phase 3

18

AD-209

AAddpharma Inc.

Phase 3

29

KSI-101

KKodiak Sciences Inc

Phase 3

210

Rengalin

MMateria Medica Holding

Phase 3

1Show 32 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Type 2 Diabetes Mellitus5 trials

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT04654390·270 enrolled

A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus

Recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT05466643·240 enrolled

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT06141980·134 enrolled

Show 2 more trials

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 2·NCT04014023·196 enrolled

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT04632862·140 enrolled

Interaction5 trials

Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05500898·53 enrolled

The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05321732·24 enrolled

Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT07213310·18 enrolled

Show 2 more trials

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04343547·34 enrolled

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04064073·34 enrolled

Tics2 trials

Pharmacokinetics and Safety Following Administration of DWP16001

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05414591·38 enrolled

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05737771·40 enrolled

Safety and Efficacy2 trials

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT05376969·159 enrolled

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT05376930·63 enrolled

Clinical Trial1 trial

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05465668·43 enrolled

8 more indications

Oral1 trial

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT03364985·123 enrolled

Hepatic Impairment1 trial

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05747664·24 enrolled

Adult1 trial

To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05797922·32 enrolled

Diabetic Nephropathy1 trial

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Not yet recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT06606093·348 enrolled

Drug Interactions1 trial

Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Not yet recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT06644404·34 enrolled

Efficacy and Safety1 trial

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Active, not recruiting·Daewoong Pharmaceutical Co. LTD.·Phase 3·NCT05505994·340 enrolled

Type 2 Diabetes1 trial

Type 2 Diabetes Patients With Renal Impairment

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04221399·35 enrolled

Unspecified2 trials

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Completed·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05192395·37 enrolled

Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

Unknown status·Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT05207176·24 enrolled

Details

Drug Info

Related News